Gene · 7272
Papers3,094
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,094
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of druggable hub genes and key pathways associated with cervical cancer by protein-protein interaction analysis: An in silico study. | Int J Reprod Biomed | 2023 | 38077941 | PubTator, text mining | PubMed |
| Identification of angiogenesis-related genes in diabetic foot ulcer using machine learning algorithms. | Heliyon | 2023 | 38076120 | PubTator, text mining | PubMed |
| Patients' perspectives on tapering programmes for prescription opioid use disorder: a qualitative study. | BMJ Open | 2023 | 38070938 | PubTator, text mining | PubMed |
| Comprehensive Profiling and Therapeutic Insights into Differentially Expressed Genes in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 38067357 | PubTator, text mining | PubMed |
| Human Embryonic Stem Cell-Derived Immature Midbrain Dopaminergic Neurons Transplanted in Parkinsonian Monkeys. | Cells | 2023 | 38067166 | PubTator, text mining | PubMed |
| CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells. | Cancer Biol Ther | 2023 | 38031910 | PubTator, text mining | PubMed |
| Transcriptional profiles of non-neuronal and immune cells in mouse trigeminal ganglia. | Front Pain Res (Lausanne) | 2023 | 38028432 | PubTator, text mining | PubMed |
| Assessment of the viability of integrating virtual reality programs in practical tests for the Korean Radiological Technologists Licensing Examination: a survey study | J Educ Eval Health Prof | 2023 | 38013201 | PubTator, text mining | PubMed |
| Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment. | Molecules | 2023 | 38005235 | PubTator, text mining | PubMed |
| RZZ-Spindly and CENP-E form an integrated platform to recruit dynein to the kinetochore corona. | EMBO J | 2023 | 37984321 | PubTator, text mining | PubMed |
| CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockade. | Nat Commun | 2023 | 37980406 | PubTator, text mining | PubMed |
| UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis. | Cell Death Dis | 2023 | 37957138 | PubTator, text mining | PubMed |
| Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications. | J Cell Biol | 2023 | 37955972 | PubTator, text mining | PubMed |
| A robust six-gene prognostic signature based on two prognostic subtypes constructed by chromatin regulators is correlated with immunological features and therapeutic response in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37938151 | PubTator, text mining | PubMed |
| The mitotic cell cycle-associated nomogram predicts overall survival in lung adenocarcinoma. | Cancer Med | 2023 | 37930238 | PubTator, text mining | PubMed |
| Efficiency of ProTaper Universal Retreatment, Reciproc Blue and XP-endo Shaper in the removal of a bioceramic-based root canal filling. | Eur Oral Res | 2023 | 37929225 | PubTator, text mining | PubMed |
| Role of Kinetochore Scaffold 1 (KNL1) in Tumorigenesis and Tumor Immune Microenvironment in Pan-Cancer: Bioinformatics Analyses and Validation of Expression. | Int J Gen Med | 2023 | 37928953 | PubTator, text mining | PubMed |
| FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma. | Oncol Lett | 2023 | 37920441 | PubTator, text mining | PubMed |
| Roles of USP9X in cellular functions and tumorigenesis (Review). | Oncol Lett | 2023 | 37920433 | PubTator, text mining | PubMed |
| Tumor vaccines: Toward multidimensional anti-tumor therapies. | Hum Vaccin Immunother | 2023 | 37905395 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7272/papers?page=14